Retatrutide, developed by Soma, represents a significant advance in body regulation. This unique compound combines incretin receptor activity with GIP pathway engagement, demonstrating remarkable efficacy in clinical studies for body improvement. Researchers believe this treatment may offer a different option for individuals facing weight-related c